Abstract:Changes in the oxidant/antioxidant environment of aging Leydig cells have been shown to be correlated with the reduced ability of these cells to produce testosterone. We hypothesized that an altered redox environment might result in increased susceptibility to pro-oxidants, and that this might have an impact on steroidogenic function. To begin to test this hypothesis, we experimentally manipulated intracellular glutathione (GSH) concentration in MA-10 Leydig cells, and examined whether the susceptibility of the GSH-depleted cells to oxidative stress was affected. Incubation of MA-10 cells with buthionine sulfoximine (BSO, 100 µM, 18 h) or diethyl maleate (DEM, 200 µM, 30 min) reduced GSH content by more than 70%, while treatment of the cells with 3H-1,2-dithiole-3-thione (D3T, 200 µM, 24 hr) increased the GSH concentration to twice that of the control cells. Depletion of GSH significantly increased the susceptibility of the cells to oxidative stress induced by tert-butyl hydroperoxide (t-BuOOH). In contrast, increasing GSH greatly protected the cells from the same stressor. Thus, the ED50 of progesterone production was reduced from 400 µM t-BuOOH in the control cells to less than 50 µM in GSH-depleted cells. Increasing GSH with D3T greatly increased the ED50 from 400 µM to more than 800 µM. Cell viability, assayed by MTT reduction and ATP production, was significantly affected by t-BuOOH only at concentrations of 100 µM or higher whereas progesterone production was affected by t-BuOOH at much lower (12.5 µM) concentration. Intracellular ROS concentration, as measured by 2, 7-dichlorodihydrofluorescein diacetate (DCF) fluorescence, was significantly increased in GSH-depleted cells in response to t-BuOOH at 50-100 µM. The changes in progesterone and ROS production induced by GSH were prevented by restoration of the cellular GSH pool with glutathione ethyl ester (GSHEE), or by treating the cells with the antioxidant N-acetyl-cysteine (NAC). Two steps of the steroidogenic pathway were particularly sensitive to oxidative stress following GSH depletion: StAR protein synthesis and the conversion of cholesterol to pregnenolone by P450scc within the mitochondria. The results of these studies, taken together, are consistent with the hypothesis that alteration in the oxidant/antioxidant environment may play a significant role in the increased sensitivity of MA-10 cells to pro-oxidant stress, and thus perhaps to the age-related reduced ability of testicular Leydig cells to produce testosterone. Research supported by NIH Grants AG026721 (to H.C.) and AG21092 (to B.R.Z.) from the National Institute on Aging and NIH Training Grant ES07141 (to A.S.M.) from the National Institute of Environmental Health Sciences.

Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase.

Type 10 17Beta-Hydroxysteroid Dehydrogenase Catalyzing the Oxidation of Steroid Modulators of Γ-Aminobutyric Acid Type A Receptors

Effect of Glutathione Depletion on Susceptibility of Ma-10 Leydig Cell Steroidogenesis to Oxidative Stress

Evaluation of 3β-hydroxysteroid dehydrogenase activity using progesterone and androgen receptors-mediated transactivation

Human 3-Alpha Hydroxysteroid Dehydrogenase Type 3 (3Α-Hsd3): the V54L Mutation Restricting the Steroid Alternative Binding and Enhancing the 20Α-Hsd Activity.

Dihydrotestosterone protects human vascular endothelial cells from H2O2-induced apoptosis through inhibition of caspase-3, caspase-9 and p38 MAPK

A Novel Compound Heterozygous CYP17A1 Variant Causes 17α-Hydroxylase/17, 20-Lyase Deficiency.

Involvement of Type 10 17β-Hydroxysteroid Dehydrogenase in the Pathogenesis of Infantile Neurodegeneration and Alzheimer's Disease

Secosteroid Mechanism-Based Inactivators and Site-Directed Mutagenesis As Probes for Steroid Hormone Recognition by 3.Alpha.-Hydroxysteroid Dehydrogenase

Characterization and Localization of Human Type10 17β‐hydroxysteroid Dehydrogenase

Differentiation-dependent expression of 17beta-hydroxysteroid dehydrogenase, type 10, in the rodent testis: effect of aging in Leydig cells

Function Of Human Brain Short Chain L-3-Hydroxyacyl Coenzyme A Dehydrogenase In Androgen Metabolism

C-3 Steroidal Hemiesters as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 10

Deacetylation of HSD17B10 by SIRT3 Regulates Cell Growth and Cell Resistance under Oxidative and Starvation Stresses

Molecular Cloning, Modeling, and Localization of Rat Type 10 17Β-Hydroxysteroid Dehydrogenase1nucleotide Sequences of Cdnas of Rat and Mouse Type 10 17Β-Hsds Have Been Deposited in the GeneBank™/EBI Data Bank with Accession Number AF069770 and AF233685, Respectively.1

Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase

Human 3 Alpha-Hydroxysteroid Dehydrogenase Type 3: Structural Clues Of 5 Alpha-Dht Reverse Binding And Enzyme Down-Regulation Decreasing Mcf7 Cell Growth

Human dehydrogenase/reductase (SDR family) member 11 is a novel type of 17β-hydroxysteroid dehydrogenase

Characterization of a Novel Thermostable 7α-Hydroxysteroid Dehydrogenase

Short-chain dehydrogenases. Proteolysis and chemical modification of prokaryotic 3 alpha/20 beta-hydroxysteroid, insect alcohol and human 15-hydroxyprostaglandin dehydrogenases

New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1